JP2006232805A - Functional drink or food - Google Patents

Functional drink or food Download PDF

Info

Publication number
JP2006232805A
JP2006232805A JP2005263779A JP2005263779A JP2006232805A JP 2006232805 A JP2006232805 A JP 2006232805A JP 2005263779 A JP2005263779 A JP 2005263779A JP 2005263779 A JP2005263779 A JP 2005263779A JP 2006232805 A JP2006232805 A JP 2006232805A
Authority
JP
Japan
Prior art keywords
tea
extract
antiallergic
food
green tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005263779A
Other languages
Japanese (ja)
Other versions
JP4788994B2 (en
JP2006232805A5 (en
Inventor
Mari Yamamoto
万里 山本
Katsunari Ipposhi
克成 一法師
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Agriculture and Food Research Organization
Original Assignee
National Agriculture and Food Research Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Agriculture and Food Research Organization filed Critical National Agriculture and Food Research Organization
Priority to JP2005263779A priority Critical patent/JP4788994B2/en
Publication of JP2006232805A publication Critical patent/JP2006232805A/en
Publication of JP2006232805A5 publication Critical patent/JP2006232805A5/ja
Application granted granted Critical
Publication of JP4788994B2 publication Critical patent/JP4788994B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drink or food obtained by combining tea leaves with a food ingredient except the tea leaves to reinforce the activity of the anti-allergic ingredient contained in the tea leaves, and to provide a method for reinforcing the same. <P>SOLUTION: This functional drink or food is characterized by containing a green tea or paochung tea extract containing an anti-allergic ingredient in an anti-allergic active ingredient amount and further containing a vegetable extract containing an anti-allergic ingredient in an anti-allergic activity-reinforcing amount. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、べにふうき、べにふじ、べにほまれ、やえほ、するがわせ、ゆたかみどり、かなやみどり、青心大パン、青心烏龍、大葉烏龍、べにひかり、やまかい、やまとみどり、おくみどり等のアッサム雑種/中国種/台湾系統/いずれかの茶葉と野菜などの食品成分の組み合わせにより抗アレルギー作用・抗炎症作用が増強された抗アレルギー性食品素材に関する。   The present invention is Benifukuki, Benifuji, Benihore, Yaeho, Sugaseru, Yutaka Midori, Kanaya Midori, Seishin Daipan, Seishin Soryu, Ooba Soryu, Benihikari, Yamakai, The present invention relates to an antiallergic food material whose antiallergic action / antiinflammatory action is enhanced by a combination of food components such as Yamato Midori, Okumidori etc. Assam hybrid / Chinese variety / Taiwan strain / any tea leaves and vegetables.

現代社会では、食生活やライフスタイルの多様化が進行すると同時に、アレルギー症状も多様化し、年々増加している。現在ではアレルギー患者は潜在的な患者を含めて3000万人と言われている。また、ステロイド等の薬剤の副作用が懸念され、アレルギー症状を自覚しているにもかかわらず薬剤の副作用を恐れ、積極的に治療に臨むことができずに症状に悩む人々もいる。そのため、抗アレルギー作用を有する成分を手軽に、かつ安心して摂取し得る飲食品の開発への消費者の期待や関心は高い。   In modern society, dietary habits and lifestyles are diversifying, and allergic symptoms are diversifying and increasing year by year. At present, it is said that there are 30 million allergic patients including potential patients. In addition, there are concerns about the side effects of drugs such as steroids, and there are some people who are unaware of allergic symptoms but are afraid of the side effects of drugs and are unable to actively treat them and suffer from symptoms. Therefore, consumers have high expectations and interest in developing foods and beverages that can easily and safely ingest ingredients having an antiallergic action.

緑茶に含まれているカテキン類、サポニン、フラボノイド、カフェインが抗アレルギー効果を持つこと(特許文献1、非特許文献1,2参照)、べにふうき、べにふじ等のメチル化カテキン含有茶葉がI型アレルギー抑制効果・抗炎症効果をもつことが報告されてきた(特許文献2参照)。   The catechins, saponins, flavonoids, and caffeine contained in green tea have antiallergic effects (see Patent Document 1, Non-Patent Documents 1 and 2), and methylated catechin-containing tea leaves such as Benifuuki and Benifuji are I. Have been reported to have a type-allergic inhibitory effect and an anti-inflammatory effect (see Patent Document 2).

中でも、べにふうき、べにふじ、べにほまれから製造した緑茶又は包種茶は、抗アレルギー作用・抗炎症作用を有し、その利用が図られてきたところである。しかし、これらの茶葉は、現時点では生産量が少なく、非常に高価である。また、これらの茶葉の効果には、個人差があるため、全ての人に効果が期待できる飲食品が求められてきた。   Among them, green tea or baled tea produced from Benifukuki, Benifuji, Benihomare has anti-allergic and anti-inflammatory effects and has been used. However, these tea leaves are currently low in production and very expensive. Moreover, since the effect of these tea leaves has an individual difference, the food / beverage products which can expect an effect for all the persons have been calculated | required.

特開2001−253879号公報JP 2001-253879 A 特願平10−346646号公報Japanese Patent Application No. 10-346646 Allergy,52,58 (1997), Fragrance J.,11,50 (1990)Allergy, 52, 58 (1997), Fragrance J. et al. , 11, 50 (1990) Biol. Pharm. Bull., 20, 565 (1997)Biol. Pharm. Bull. , 20, 565 (1997)

緑茶に含まれているカテキン類、サポニン、フラボノイド、カフェインが抗アレルギー効果を持つこと(特許文献1、非特許文献1,2参照)、べにふうきなどのメチル化カテキン含有茶葉がI型アレルギー抑制効果・抗炎症効果をもつこと等が報告されてきた(特許文献2参照)。しかし、これらはいずれも茶葉のみを用いて抗アレルギー効果を期待するというものであり、茶葉にそれ以外の食品成分を組み合わせてその効果を高めるというアプローチはされてこなかった。   Catechins, saponins, flavonoids, and caffeine contained in green tea have anti-allergic effects (see Patent Document 1, Non-Patent Documents 1 and 2), and methylated catechin-containing tea leaves such as Benifuuki have type I allergy inhibitory effects -It has been reported that it has an anti-inflammatory effect (see Patent Document 2). However, these are all expected to have an anti-allergic effect using only tea leaves, and no approach has been made to enhance the effect by combining tea leaves with other food ingredients.

以上のような課題に鑑み本発明では、茶葉に茶葉以外の食品成分を組み合わせ、茶葉が有する抗アレルギー成分の活性を増強させることを目的とし、それによって得られた飲食品及び、その増強方法を提供する。   In view of the problems as described above, the present invention combines food ingredients other than tea leaves with tea leaves, and aims to enhance the activity of anti-allergic ingredients possessed by tea leaves. provide.

以下、本発明について詳しく説明する。   The present invention will be described in detail below.

(1) 抗アレルギー成分を含有する緑茶若しくは包種茶の抽出物を抗アレルギー有効成分量含有し、かつ、抗アレルギー成分活性物質を含有する野菜抽出物を、少なくとも抗アレルギー成分活性増強量含有する機能性飲食品。   (1) Contains an anti-allergic active ingredient amount of an extract of green tea or baling tea containing an anti-allergic component, and contains at least an anti-allergic component activity enhancing amount of a vegetable extract containing an anti-allergic component active substance Functional food and drink.

(1)の発明によれば、抗アレルギー成分を含有する緑茶若しくは包種茶の抽出物に、野菜抽出物を添加したことによって、茶葉が含有する抗アレルギー成分を活性化することが可能となる。従って、従来よりも少ない量の茶葉で同等の抗アレルギー作用を奏することが可能な飲食品を提供することができる。   According to the invention of (1), it becomes possible to activate the anti-allergic component contained in the tea leaves by adding the vegetable extract to the extract of the green tea or the baled tea containing the anti-allergic component. . Therefore, the food / beverage products which can show | play an equivalent antiallergic action with the tea leaf of the quantity smaller than before can be provided.

「抗アレルギー有効成分量」とは、抗アレルギー作用を奏する有効成分が、十分な効果を奏すると判断される場合の含有量をいう。また「抗アレルギー成分活性物質」とは、抗アレルギー成分の活性を増強させることが可能な物質をいう。また「抗アレルギー成分活性増強量」とは、上記抗アレルギー成分の抗アレルギー活性を、1.5倍から10倍程度増強させることが可能な量をいう。   “Anti-allergic active ingredient amount” refers to the content when an active ingredient having anti-allergic action is judged to have a sufficient effect. The “antiallergic component active substance” refers to a substance capable of enhancing the activity of the antiallergic component. Further, the “antiallergic component activity enhancing amount” refers to an amount capable of enhancing the antiallergic activity of the antiallergic component by about 1.5 to 10 times.

(2) 前記抗アレルギー成分は、メチル化カテキンである(1)に記載の機能性飲料。   (2) The functional beverage according to (1), wherein the antiallergic component is methylated catechin.

上記茶葉に含有されている抗アレルギー成分として、カテキン類が挙げられる。中でも下記の一般式(1)で示されるメチル化カテキンは、強い抗アレルギー作用を奏する。従って、(2)の発明によれば、抗アレルギー成分をメチル化カテキンとしたことによって、より強い抗アレルギー作用を奏することができる。

Figure 2006232805
[R,R,R,Rは、それぞれ独立に水素原子、メチル基のいずれかであり、X,Xは、それぞれ独立に水素原子、ヒドロキシ基のどちらかである。] Examples of the antiallergic component contained in the tea leaves include catechins. Among them, methylated catechin represented by the following general formula (1) exhibits a strong antiallergic action. Therefore, according to the invention of (2), a stronger antiallergic action can be achieved by using methylated catechin as the antiallergic component.
Figure 2006232805
[R 1 , R 2 , R 3 , R 4 are each independently a hydrogen atom or a methyl group, and X 1 , X 2 are each independently a hydrogen atom or a hydroxy group. ]

(3) 前記緑茶又は包種茶は、べにふうき、べにふじ、べにほまれ、やえほ、するがわせ、ゆたかみどり、かなやみどり、青心大パン、青心烏龍、大葉烏龍、べにひかり、やまかい、やまとみどり、おくみどり、台湾系統種、中国種もしくはこれらの混合物の茶葉である(1)又は(2)に記載の機能性飲食品。   (3) The green tea or baled tea is Benifuuki, Benifuji, Benihore, Yaeho, Shirase, Yutaka Midori, Kanaya Midori, Seishin Daipan, Seishin Oolong, Ooba Oolong, The functional food or drink according to (1) or (2), which is a tea leaf of Benihikari, Yamakai, Yamato Midori, Okumidori, Taiwanese species, Chinese species or a mixture thereof.

メチル化カテキンは、上記の品種の茶葉固有のものであるため、(3)の発明によればこれらの品種の茶葉を用いたことによって、抗アレルギー効果をより効率よく増強させることができる。従って、従来よりも少ない量の茶葉でも十分な抗アレルギー作用を奏する飲食品を提供することができる。なお、メチル化カテキンを含有する茶葉として上記の品種の茶葉を挙げたが、特にこれらの品種に限られるものではない。   Since methylated catechins are unique to the tea varieties of the above varieties, according to the invention of (3), the antiallergic effect can be enhanced more efficiently by using tea varieties of these varieties. Therefore, it is possible to provide a food or drink that exhibits a sufficient antiallergic action even with a smaller amount of tea leaves than in the past. In addition, although the tea leaves of the above-mentioned varieties were listed as tea leaves containing methylated catechins, they are not particularly limited to these varieties.

(4) 前記野菜抽出物は、ショウガ、大根、キャベツ、ルッコラスプラウト、かいわれ大根、レッドキャベツスプラウト、ブロッコリスプラウト、フキ、ゴボウ、きゅうり、ナス、白菜、レタス、ラッキョウ、玉ねぎ、長ネギ、カブ、シソ若しくはこれらの抽出物の混合物である(1)から(3)いずれかに記載の機能性飲食品。   (4) The vegetable extract is ginger, radish, cabbage, arugula sprout, scalloped radish, red cabbage sprout, broccoli sprout, buffalo, burdock, cucumber, eggplant, Chinese cabbage, lettuce, raccoon, onion, long onion, turnip, perilla or The functional food or drink according to any one of (1) to (3), which is a mixture of these extracts.

上記の野菜にはフラボノイドの一種であるケルセチンやケンフェノールやアリル化合物(イソチアネート等)が含有されている。これらは抗酸化活性が高いため、動脈硬化の予防や癌予防へ期待されている。しかしながら、本発明においてこれらの野菜抽出物が、カテキン類の抗アレルギー作用を増強させることが可能であることが見出された。そのため、(4)の発明によれば、上記の野菜抽出物と茶葉抽出物とを組み合わせたことによって、茶葉が含有する抗アレルギー成分をより活性化することが可能となる。   The above vegetables contain quercetin, kenphenol, and allyl compounds (such as isothiocyanates), which are a kind of flavonoid. Since these have high antioxidant activity, they are expected to prevent arteriosclerosis and cancer. However, it has been found in the present invention that these vegetable extracts can enhance the antiallergic action of catechins. Therefore, according to the invention of (4), it becomes possible to further activate the antiallergic components contained in tea leaves by combining the vegetable extract and the tea leaf extract.

(5) 前記緑茶又は包種茶の抽出物又は粉末を、100ml当たり50mgから50g又は100mg当たり5mgから80mg含有する(1)から(4)いずれかに記載の機能性飲食品。   (5) The functional food or drink according to any one of (1) to (4), wherein the extract or powder of the green tea or confectionery tea contains 50 mg to 50 g per 100 ml or 5 mg to 80 mg per 100 mg.

(5)の発明によれば、抽出物又は茶葉粉末の含有量を上記の量としたことによって、十分な抗アレルギー作用を奏する飲食品を提供することが可能となる。含有量が5mg未満であると十分な抗アレルギー作用を奏することができない。また、含有量が50gを超えると飲食品の風味が落ちてしまう可能性がある。   According to the invention of (5), by setting the content of the extract or tea leaf powder to the above-mentioned amount, it is possible to provide a food or drink that exhibits a sufficient antiallergic action. If the content is less than 5 mg, sufficient antiallergic action cannot be achieved. Moreover, when content exceeds 50 g, the flavor of food-drinks may fall.

(6) 前記野菜抽出物を、100ml当たり2mlから50ml又は100mg当たり1mgから80mg含有する(1)から(5)いずれかに記載の機能性飲食品。   (6) The functional food or drink according to any one of (1) to (5), wherein the vegetable extract contains 2 to 50 ml per 100 ml or 1 to 80 mg per 100 mg.

(6)の発明によれば、野菜抽出物の含有量を上記の量としたことによって、茶葉抽出物の有する抗アレルギー成分の抗アレルギー活性を増強させることが可能となる。含有量が2ml又は1mg未満であると十分な抗アレルギー活性を増強させることができない。また、含有量が50ml又は80mgを超えると飲食品の風味が落ちてしまう可能性がある。   According to the invention of (6), the antiallergic activity of the antiallergic component of the tea leaf extract can be enhanced by setting the content of the vegetable extract to the above amount. If the content is less than 2 ml or 1 mg, sufficient antiallergic activity cannot be enhanced. Moreover, when content exceeds 50 ml or 80 mg, the flavor of food-drinks may fall.

(7) 抗アレルギー成分を含有する緑茶又は包種茶の抽出物に、野菜抽出物を添加することによって前記抗アレルギー成分の抗アレルギー活性を増強させる方法。   (7) A method of enhancing the antiallergic activity of the antiallergic component by adding a vegetable extract to an extract of green tea or bun seed tea containing the antiallergic component.

(8) 前記抗アレルギー成分は、メチル化カテキンである(7)に記載の方法。   (8) The method according to (7), wherein the antiallergic component is methylated catechin.

本発明に係る機能性飲食品によれば、野菜抽出物を添加したことによって、茶葉が含有する抗アレルギー成分を活性化することが可能となる。そのため、従来よりも少ない量の茶葉で同等の抗アレルギー作用を奏することが可能な飲食品を提供することができる。   According to the functional food / beverage products which concern on this invention, it becomes possible to activate the antiallergic component which a tea leaf contains by adding a vegetable extract. Therefore, the food / beverage products which can show | play an equivalent antiallergic effect with the tea leaf of the quantity smaller than before can be provided.

以下、本発明について詳しく説明する。   The present invention will be described in detail below.

[飲食品の製造]
本発明に係る機能性飲食品は、所定の茶葉由来のメチル化カテキン成分を有効成分量含有する。ここで「メチル化カテキン」とは、一般式(1)で示されるものであり、メチル化されたカテキン及び精製の際の不可避成分をいう。本発明におけるメチル化カテキンは主として、エピカテキン−3−O−(3−O−メチル)ガレート(以下、ECG3”Meという)、エピカテキン−3−O−(4−O−メチル)ガレート(以下、ECG4”Meという)、エピガロカテキン−3−O−(4−O−メチル)ガレート(以下、EGCG4”Meという)、ガロカテキン−3−O−(3−O−メチル)ガレート(以下、GCG3”Meという)、カテキン−3−O−(3−O−メチル)ガレート(以下、CG3”Meという)、カテキン−3−O−(4−O−メチル)ガレート(以下、CG4”Meという)、又は、ガロカテキン−3−O−(4−O−メチル)ガレート(以下、GCG4”Meという)、エピガロカテキン−3−O−(3−O−メチル)ガレート(以下、EGCG3”Meとする)及びこれらの異性化体を含むことが好ましい。

Figure 2006232805
[R,R,R,Rは、それぞれ独立に水素原子、メチル基のいずれかであり、X,Xは、それぞれ独立に水素原子、ヒドロキシ基のどちらかである。] [Manufacture of food and drink]
The functional food / beverage products which concern on this invention contain the methylated catechin component derived from a predetermined tea leaf in an active ingredient amount. Here, “methylated catechin” is represented by the general formula (1), and refers to methylated catechin and inevitable components during purification. The methylated catechins in the present invention are mainly epicatechin-3-O- (3-O-methyl) gallate (hereinafter referred to as ECG3 "Me), epicatechin-3-O- (4-O-methyl) gallate (hereinafter referred to as ECG3" Me). ECG4 "Me", epigallocatechin-3-O- (4-O-methyl) gallate (hereinafter referred to as EGCG4 "Me), gallocatechin-3-O- (3-O-methyl) gallate (hereinafter referred to as GCG3). "Me", catechin-3-O- (3-O-methyl) gallate (hereinafter referred to as CG3 "Me), catechin-3-O- (4-O-methyl) gallate (hereinafter referred to as CG4" Me) Or gallocatechin-3-O- (4-O-methyl) gallate (hereinafter referred to as GCG4 "Me), epigallocatechin-3-O- (3-O-methyl) gallate (hereinafter referred to as EG). G3 "and Me) and it is preferable to include these isomerate.
Figure 2006232805
[R 1 , R 2 , R 3 , R 4 are each independently a hydrogen atom or a methyl group, and X 1 , X 2 are each independently a hydrogen atom or a hydroxy group. ]

茶葉抽出物は、所定の茶葉からメチル化カテキンを従来公知の方法を用いて抽出して得られる。メチル化カテキンを含有している所定の茶葉としては、「べにふうき」、「べにふじ」、「べにほまれ」、「やえほ」、「するがわせ」、「ゆたかみどり」、「かなやみどり」、「おくむさし」、「青心大パン」、「青心烏龍」、「大葉烏龍」、「鳳凰単叢」、「鳳凰水仙」、「白葉単叢水仙」、「黄枝香」、「武夷水仙」、「紅花」、「べにひかり」、「やまかい」、「やまみどり」、「からべに」、「香駿」、及び「おくみどり」、もしくはこれらの混合物などが挙げられる。これらの茶葉を単一種又は複数種混合して用いてもよい。   The tea leaf extract is obtained by extracting methylated catechin from a predetermined tea leaf using a conventionally known method. The specified tea leaves containing methylated catechins include “Benifuuki”, “Benifuji”, “Benihoare”, “Yaeho”, “Surugaze”, “Yutaka Midori”, “Kanaya” `` Midori '', `` Okumusashi '', `` Aoshin Daipan '', `` Aoshin Soryu '', `` Ooba Soryu '', `` Aoi Monoplex '', `` Suisuisen '', `` Shiraba Monoplex Daffodil '', Examples include “Wuyi Daffodil”, “Safflower”, “Benihikari”, “Yamakai”, “Yamamidori”, “Karabeni”, “Kaori”, “Okumidori”, or a mixture thereof. . These tea leaves may be used alone or in combination.

また、抽出の際の温度は、溶媒の融点より高く、沸点より低い温度であれば、特に限定されるものではないが、水では10℃から100℃、エタノールおよびメタノールでは10℃から40℃が望ましい。抽出時間は10秒から24時間の範囲とすることが好ましい。   Further, the temperature at the time of extraction is not particularly limited as long as it is higher than the melting point of the solvent and lower than the boiling point, but it is 10 ° C. to 100 ° C. for water and 10 ° C. to 40 ° C. for ethanol and methanol. desirable. The extraction time is preferably in the range of 10 seconds to 24 hours.

例えば、乾燥させた茶葉を破砕、粉砕等により粉末化処理したものに、抽出溶媒を添加して抽出物又はその処理物として用いることが好ましい。抽出溶媒としては、水;低級アルコール類、例えばメタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール;エーテル類、例えばエチルエーテル、ジオキサン;ケトン類、例えばアセトン等が挙げられるが、水、エタノール、又は水−エタノール混合溶媒が好ましい。   For example, it is preferable to add an extraction solvent to the dried tea leaves that have been pulverized, pulverized, etc., and used as an extract or a processed product thereof. Examples of the extraction solvent include water; lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol; ethers such as ethyl ether, dioxane; ketones such as acetone, but water, ethanol, or A water-ethanol mixed solvent is preferred.

得られた抽出物は、そのまま飲食品に添加してもよいが、精製物を添加してもよい。抽出物の精製は、化学分離精製手法として一般的に用いられる方法を使用することが好ましい。例えば、液−液分配、薄層クロマトグラフィー、吸着カラムクロマトグラフィー、分配カラムクロマトグラフィー、ゲルろ過カラムクロマトグラフィー、イオン交換カラムクロマトグラフィー、電気泳動や高速液体クロマトグラフィーなどを用いることができる。また、必要に応じこれらの分離精製手段を組み合わせて行なってもよい。   Although the obtained extract may be added to food and drink as it is, a purified product may be added. For the purification of the extract, it is preferable to use a method generally used as a chemical separation and purification method. For example, liquid-liquid distribution, thin layer chromatography, adsorption column chromatography, distribution column chromatography, gel filtration column chromatography, ion exchange column chromatography, electrophoresis, high performance liquid chromatography and the like can be used. Moreover, you may carry out combining these isolation | separation purification means as needed.

また、野菜抽出物も茶葉抽出物と同様の方法で製造する。具体的には、乾燥した野菜を破砕、粉砕等により粉末化処理したものに、上記の抽出溶媒を添加して抽出物又はその処理物として用いることが好ましい。   The vegetable extract is also produced by the same method as the tea leaf extract. Specifically, it is preferable to add the above extraction solvent to a dried vegetable powder that has been pulverized, pulverized, or the like and used as an extract or a processed product thereof.

なお、飲料及び食品中で、上記のメチル化カテキンが十分な抗アレルギー作用を奏するために酸化防止剤、香料、各種エステル類、有機酸類、有機酸塩類、無機酸類、無機酸塩類、無機塩類、色素類、乳化剤、保存料、調味料、甘味料、酸味料、果汁エキス類、野菜エキス類、花蜜エキス類、pH調整剤、品質安定剤などの添加剤を単独、あるいは併用して配合しても良い。   In addition, in beverages and foods, the above-mentioned methylated catechins have sufficient antiallergic action, so that antioxidants, fragrances, various esters, organic acids, organic acid salts, inorganic acids, inorganic acid salts, inorganic salts, Additives such as pigments, emulsifiers, preservatives, seasonings, sweeteners, acidulants, fruit juice extracts, vegetable extracts, nectar extracts, pH adjusters, quality stabilizers, etc. alone or in combination Also good.

例えば甘味料としては、砂糖、ぶどう糖、果糖、異性化液糖、グリチルリチン、ステビア、アスパルテーム、フラクトオリゴ糖、ガラクトオリゴ糖等が挙げられる。酸味料としては、天然成分から抽出した果汁類のほか、クエン酸、酒石酸、リンゴ酸、乳酸、フマル酸、リン酸が挙げられる。クエン酸もしくはリンゴ酸を飲料中に0.1g/Lから5g/L、好ましくは0.5g/Lから2g/L含有するのがよい。酸化防止剤としては、L−アスコルビン酸、L−アスコルビン酸ナトリウム、エリソルビン酸、エリソルビン酸ナトリウム、があげられる。飲料中に、0.005質量%から0.5質量%、好ましくは0.01質量%から0.1質量%含有するのがよい。   Examples of sweeteners include sugar, glucose, fructose, isomerized liquid sugar, glycyrrhizin, stevia, aspartame, fructooligosaccharide, and galactooligosaccharide. Examples of acidulants include fruit juices extracted from natural ingredients, citric acid, tartaric acid, malic acid, lactic acid, fumaric acid, and phosphoric acid. Citric acid or malic acid is contained in the beverage in an amount of 0.1 g / L to 5 g / L, preferably 0.5 g / L to 2 g / L. Examples of the antioxidant include L-ascorbic acid, sodium L-ascorbate, erythorbic acid, and sodium erythorbate. It is good to contain 0.005 mass% to 0.5 mass% in a drink, Preferably it is 0.01 mass% to 0.1 mass%.

飲料に使用される容器は、一般の飲料と同様にポリエチレンテレフタレートを主成分とする成形容器(いわゆるPETボトル)、金属缶、金属箔やプラスチックフィルムと複合された紙容器、瓶などの通常の形態で提供することができる。   Containers used for beverages are ordinary forms such as molded containers mainly composed of polyethylene terephthalate (so-called PET bottles), metal cans, paper containers combined with metal foil or plastic film, bottles, etc. Can be offered at.

また、上記の容器は例えば、金属缶のように容器に充填後、加熱殺菌できる場合にあっては食品衛生法に定められた所定の殺菌条件で製造される。PETボトル、紙容器のようにレトルト殺菌できないものについては、あらかじめ上記と同等の殺菌条件、例えばプレート式熱交換器などで高温短時間殺菌後、一定の温度まで冷却して、容器に充填する等の方法が採用される。また無菌下で、充填された容器に別の成分を配合して充填してもよい。さらに、酸性下で加熱殺菌後、無菌下でpHを中性に戻すことや、中性下で加熱殺菌後、無菌下でpHを酸性に戻すなどの操作も可能である。   Moreover, said container is manufactured on the predetermined | prescribed sterilization conditions prescribed | regulated to the food hygiene law, for example, when it can heat-sterilize after filling a container like a metal can. For PET bottles and paper containers that cannot be sterilized by retort, sterilize under the same conditions as above, for example, sterilize at high temperature and short time in a plate heat exchanger, then cool to a certain temperature, and fill the container. The method is adopted. Moreover, you may mix | blend another component with the filled container under aseptic conditions. Furthermore, after sterilization by heating under acidic conditions, the pH can be returned to neutrality under aseptic conditions, or after sterilization by heating under neutral conditions, the pH can be returned to acidic conditions under aseptic conditions.

また、食品に使用する場合は、特定保健用食品、特殊栄養食品、栄養補助食品、健康食品などに食品添加物として配合することができる。添加対象の食品としては、各種食品に可能である。飲料としては、特定保健用食品、特殊栄養食品、栄養補助食品としての飲料やその他の栄養飲料、健康飲料、各種の健康茶、その他の飲料などに配合できる。他の食品としては、菓子類、パン、麺類、大豆加工品、乳製品、卵加工品、練り製品、油脂、調味料等が挙げられる。   Moreover, when using for foodstuffs, it can mix | blend with foodstuffs for special health, special nutrition foods, dietary supplements, health foods, etc. as a food additive. The food to be added can be various foods. As a drink, it can mix | blend with the food for specific health, the special nutrition food, the drink as a dietary supplement, other nutrition drinks, health drinks, various health teas, other drinks, etc. Examples of other foods include confectionery, bread, noodles, processed soybean products, dairy products, processed egg products, kneaded products, fats and oils, and seasonings.

<実施例1>
マスト細胞からの炎症性サイトカイン産生抑制活性に及ぼす組み合わせ効果について検討した。茶葉抽出液には、2.5gのべにふうき茶葉粉末を25mlの熱水で10分抽出し、濾過した上清を用いた。上清はタンニン含量を酒石酸鉄法で測定し、タンニン含量で細胞1×10個当り50mg添加した。野菜抽出液は、それぞれの野菜(ブロッコリスプラウト、かいわれ大根、レッドキャベツスプラウト、ルッコラスプラウト、ショウガ)5gに5mlの50%エタノールを添加して乳鉢でよくすりつぶした。これを3000rpmで15分遠心後、上清を1×10個当り50ml添加した。得られた飲料を試験飲料1から5とした。
<Example 1>
The combined effect on the suppressive activity of inflammatory cytokine production from mast cells was examined. As the tea leaf extract, 2.5 g of Benifukuki tea leaf powder was extracted with 25 ml of hot water for 10 minutes, and the filtered supernatant was used. The supernatant was measured for the tannin content by the iron tartrate method, and 50 mg was added per 1 × 10 7 cells as the tannin content. The vegetable extract was crushed well in a mortar by adding 5 ml of 50% ethanol to 5 g of each vegetable (broccoli sprout, red radish, red cabbage sprout, arugula sprout, ginger). After centrifugation at 3000 rpm for 15 minutes, 50 ml of the supernatant was added per 1 × 10 7 pieces. The obtained beverages were designated as test beverages 1 to 5.

マウス骨髄由来培養マスト細胞(BMMC)は、マウス骨髄から分離した細胞を30ng/mlマウスIL−3(和光純薬、東京)、5%非働化FBS(Invitrogen, USA)添加RPMI1640(大日本製薬、東京)培地で4週間培養することで得た。BMMCを抗DNP−IgE抗体(Sigma Aldrich, USA)で1晩感作(0.5mg/2×10cells)し、前述の各抽出液を添加して10分後、DNP−HSA(Cosmo−Bio, Tokyo) 300ng/mlで刺激して2時間後、上清を回収し、Bio−plexプロテインサスペンジョンアレイ(Bio−Rad, USA)でサイトカイン量を測定した。なお、測定したサイトカインは、IL−1a、IL−1b、IL−2、IL−3、IL−4、IL−5、IL−6、IL−10、IL−12(p40)、IL−12(p70)、IL−17、IFN−g、TNF−a、GM−CSF、KC、MIP1−a、RANTESである。 Mouse bone marrow-derived cultured mast cells (BMMC) were prepared from 30 ng / ml mouse IL-3 (Wako Pure Chemicals, Tokyo), RPMI 1640 (Dainippon Pharmaceutical Co., Ltd.) with 5% inactivated FBS (Invitrogen, USA) (Tokyo) It was obtained by culturing in a medium for 4 weeks. BMMC was sensitized overnight with anti-DNP-IgE antibody (Sigma Aldrich, USA) (0.5 mg / 2 × 10 6 cells), 10 minutes after adding each of the aforementioned extracts, DNP-HSA (Cosmo- (Bio, Tokyo) 2 hours after stimulation with 300 ng / ml, the supernatant was collected, and the amount of cytokine was measured with a Bio-plex protein suspension array (Bio-Rad, USA). The cytokines measured were IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12 (p40), IL-12 ( p70), IL-17, IFN-g, TNF-a, GM-CSF, KC, MIP1-a, and RANTES.

プロテインサスペンジョンアレイを用いてBMMCからのサイトカイン産生を調べたところ、抗原刺激後2時間で、IL−2、IL−5、IL−6、IL−17、GM−CSF、TNF−a、MIP−1aで抗原刺激による数値の変動が認められた。特に、炎症性サイトカインTNF−a(腫瘍壊死因子)、MIP−1a(好酸球遊走因子)は刺激により多量に産生された。   Cytokine production from BMMC was examined using a protein suspension array. IL-2, IL-5, IL-6, IL-17, GM-CSF, TNF-a, MIP-1a were obtained 2 hours after antigen stimulation. In the results, changes in numerical values due to antigen stimulation were observed. In particular, the inflammatory cytokines TNF-a (tumor necrosis factor) and MIP-1a (eosinophil migration factor) were produced in large amounts upon stimulation.

図1に「べにふうき」緑茶熱水抽出液及び野菜抽出液のTNF−a産生への影響を示した。「べにふうき」緑茶に組み合わせた野菜は、ブロッコリスプラウト、かいわれ大根、レッドキャベツスプラウト、ルッコラスプラウト、ショウガである。「べにふうき」緑茶のみでもTNF−a産生を約40%抑制したが、野菜ではショウガのみが単体でTNF−a産生を約70%抑制した。ブロッコリスプラウト、カイワレ大根と「べにふうき」緑茶を組み合わせることにより、産生抑制率が約2倍になった。特に、ショウガとの組み合わせにおいてTNF−a産生は95%抑制され、「べにふうき」緑茶とショウガエキスの組み合わせは、マスト細胞抗原刺激後のサイトカイン産生を強く抑制し、強い抗アレルギー効果が期待された。   FIG. 1 shows the effect of “Benifuuki” green tea hot water extract and vegetable extract on TNF-a production. Vegetables combined with “Benifuuki” green tea are broccoli sprout, kaidai radish, red cabbage sprout, arugula sprout and ginger. “Benifuuki” green tea alone suppressed TNF-a production by about 40%, but in vegetables, only ginger alone suppressed TNF-a production by about 70%. Combining broccoli sprout, daikon radish and “Benifuuki” green tea doubled the production inhibition rate. In particular, TNF-a production was suppressed by 95% in combination with ginger, and the combination of “Benifuuki” green tea and ginger extract strongly suppressed cytokine production after mast cell antigen stimulation, and a strong antiallergic effect was expected.

<実施例2>
アレルギー性鼻炎軽症者における「べにふうき」緑茶とショウガエキスの同時摂取試験を行なった。被験者には、医療機関で治療を受けておらず、かつ、スギ花粉症状を有し、スギ特異的IgE値がプラスである27名(年齢23歳から59歳、男性18名(平均年齢40.4歳)、女性9名(平均年齢37.8歳))を選択した。
<Example 2>
A simultaneous intake test of “Benifuuki” green tea and ginger extract was conducted in patients with mild allergic rhinitis. There were 27 subjects (age 23-59 years old, 18 men (average age 40. 5) who had not been treated at a medical institution, had cedar pollen symptoms, and had a positive cedar-specific IgE value. 4 years) and 9 women (average age 37.8 years)) were selected.

試験飲料には、「べにふうき」茶葉粉末(1.5g/回)及び30mgショウガエキス(アルプス薬品製)配合「べにふうき」緑茶粉末(50%平均粒径が約20ml、1.5g/回)を用いた。表1に化学成分の含有量を示す。この粉末を摂取開始から摂取終了まで朝、昼1回ずつ、湯に溶かして飲用させた。この被験品は、1回あたり22.35mgのメチル化カテキンを含有している。   "Benifuuki" green tea powder (50% average particle size is about 20ml, 1.5g / time) containing "Benifuuki" tea leaf powder (1.5g / time) and 30mg ginger extract (Alps Pharmaceutical) It was. Table 1 shows the contents of chemical components. This powder was drunk in hot water once a day in the morning from the start of intake to the end of intake. This test article contains 22.35 mg of methylated catechin per serving.

なお、比較飲料として、「やぶきた」緑茶粉末(1.5g/回)を用いた。この飲料も被験品と全く同じとした。   In addition, “Yabukita” green tea powder (1.5 g / time) was used as a comparative beverage. This beverage was exactly the same as the test product.

Figure 2006232805
Figure 2006232805

試験は次のような手順で行なった。試験飲料の摂取開始前5日間及び、摂取後5日間を観察期間とし、試験飲料の摂取開始日、28日目、56日目、86日目にそれぞれ被験者に対し、管理医師の問診、血圧測定、採尿、採血を行った。   The test was performed in the following procedure. The observation period is 5 days before the start of intake of the test beverage and 5 days after the start of intake. Urine collection and blood collection were performed.

採取した血液は、血球計測装置で、白血球数(WBC)、赤血球数(RBC)、ヘモグロビン、ヘマトリクット、血小板数、平均血球容積(MCV)、平均赤血球血色素量(MCH)、平均赤血球血色素濃度(MCHC)、好酸球数の各項目を、総タンパク質をビューレット法で、アルブミンをBCG法で、グルタミルオキザロ酢酸トランスアミナーゼ(GOT)、グルタミルピルビン酸トランスアミナーゼ(GPT)、アルカリフォスファターゼ(ALP)、γ−グルタミルトランスペプチダーゼ(γ−GTP)をUV法で、クレアチニンをヤッフェ法で、尿酸、中性脂肪(TG)、総コレステロール(T−chol)、HDLコレステロール(HDL−chol)を酵素法で、ヒスタミン、総IgG、抗原特異的IgE及び好塩基球塩基性タンパク質(Eosionophil cationic protein:ECP)をFEIA法で、サイトメガロウイルス抗体(CMV)を補体結合試験法で、血清鉄を比色法でそれぞれ測定した。また採尿時にタンパク質、糖、ウロビリノーゲンを試験紙法で調査した。上記の血液学検査、一般臨床検査、サイトカイン検査等については三菱化学ビーシーエル(株)にて行った。   The collected blood was measured with a blood cell counter using a white blood cell count (WBC), red blood cell count (RBC), hemoglobin, hematotric, platelet count, average blood cell volume (MCV), average red blood cell pigment content (MCH), and average red blood cell blood pigment concentration (MCHC). ), The number of eosinophils, the total protein by the Burette method, the albumin by the BCG method, glutamyl oxaloacetate transaminase (GOT), glutamylpyruvate transaminase (GPT), alkaline phosphatase (ALP), γ-glutamyl Transpeptidase (γ-GTP) by UV method, creatinine by Jaffle method, uric acid, neutral fat (TG), total cholesterol (T-chol), HDL cholesterol (HDL-chol) by enzymatic method, histamine, total IgG, antigen-specific IgE and basophil basicity Protein (Eosionophilic protein: ECP) was measured by FEIA method, cytomegalovirus antibody (CMV) was measured by complement binding test method, and serum iron was measured by colorimetric method. Proteins, sugars, and urobilinogen were examined using a test paper method at the time of urine collection. The above hematology test, general clinical test, cytokine test, etc. were performed by Mitsubishi Chemical BLC.

その結果を表2から7に示す。スギ特異的IgE、ヒノキ特異的IgE、ヒスタミン、ECPを測定したが、スギ花粉飛散量が増加しても、各群とも有意な変動は認められなかった。CD23のみ、比較飲料を摂取した対照群(摂取56日目)及び試験飲料を摂取したべにふうき群及びべにふうきショウガ群(摂取86日目)で摂取開始時の値に比べ有意に上昇した。   The results are shown in Tables 2 to 7. Japanese cedar specific IgE, Japanese cypress specific IgE, histamine, and ECP were measured. Even if the amount of cedar pollen scattering increased, no significant change was observed in each group. Only for CD23, the control group (ingestion day 56) that ingested the comparative beverage, and the benifuuki group and the benifugi ginger group (ingestion day 86) that ingested the test beverage significantly increased compared to the values at the start of ingestion.

Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805
Figure 2006232805

また、被験者全員によるアレルギー日誌を日本アレルギー学会アレルギー性鼻炎委員会の提唱する方法に準拠して作成した。日誌の記載は、くしゃみ及び鼻かみの回数、鼻づまり、眼のかゆみ、咽頭痛、生活への支障度について、症状の程度に相当する5段階評点(1(なにもない)〜5(とてもひどい))及び医薬品の服薬状況を1日1回、夜に記入させた。日誌は試験終了時に回収して解析を行った。アレルギー性鼻炎診療ガイドラインの指針17に従って鼻症状のSymptom Score、 Medication Score(医薬品の服用点数)、これら両スコアを合算したSymptom−Medication Scoreを算出した。   In addition, an allergy diary of all subjects was prepared in accordance with the method proposed by the Japanese Allergic Society Allergic Rhinitis Committee. The diary describes the number of sneezing and nasal congestion, stuffy nose, itchy eyes, sore throat, and the degree of disability in life, on a five-point scale (1 (nothing) to 5 (very) Terrible)) and medication status once a day at night. Diaries were collected and analyzed at the end of the study. In accordance with the guideline 17 of the allergic rhinitis clinical practice guideline, the Symptom Score of the nasal symptoms, the Medicine Score (the number of medicines taken), and the Symptom-Mediation Score obtained by adding up both these scores were calculated.

また、鼻炎の自覚症状に関しては、2週間毎のスコアの頻度を統計解析の対象とし、Mann−Whitney U検定により試験群間の比較を行った。また同一試験群内における前観察期間と各試験期間の有意差については、Wilcoxon&Bonferroniの不等式の修正による検定により評価した。血液検査値を始めとする上記以外の検査値についてはパラメトリック法により統計解析し、試験群間の比較には対応のないt検定を用いた。また同一試験群内での摂取開始日とその他の試験日の変動については、試験期間中3回以上測定した項目には二元配置分散分析を行った後、下位検定としてDunnet検定を行うことで比較を行った。   In addition, regarding subjective symptoms of rhinitis, the frequency of scores every two weeks was subjected to statistical analysis, and comparison was made between test groups by Mann-Whitney U test. Moreover, the significant difference between the previous observation period and each test period in the same test group was evaluated by a test by correcting the inequality of Wilcoxon & Bonferroni. Test values other than the above, including blood test values, were statistically analyzed by the parametric method, and unmatched t-test was used for comparison between test groups. In addition, regarding the fluctuation of the start date of intake and other test days within the same test group, after performing a two-way analysis of variance for items measured three or more times during the test period, the Dunnet test is performed as a subordinate test. A comparison was made.

アレルギー日誌のスコアを図2から7に示す。これより、本発明に係る飲料を摂取した場合は、咽頭痛の11週及び13週で対照群に比べ有意な差が認められた。また、鼻symptom scoreでは11週ショウガエキス入り「べにふうき」緑茶群が対照群に比べ有意に悪化が軽減された。鼻symptom medication scoreにおいても、11週及び13週でショウガエキス入り「べにふうき」緑茶群で対照群に比して症状の軽減が確認された。   The scores of the allergy diary are shown in FIGS. From this, when the beverage according to the present invention was ingested, a significant difference was observed in the 11th and 13th weeks of sore throat compared to the control group. In the nasal symptom score, the “Benifuuki” green tea group containing ginger extract for 11 weeks was significantly reduced compared to the control group. In the nasal symptom indication score, the reduction of symptoms was confirmed in the “Benifuuki” green tea group with ginger extract at 11 and 13 weeks compared to the control group.

また、尿検査では、タンパク質、糖、ウロビリノーゲンを測定したが、摂取による各群の変動は認められなかった。   In urinalysis, protein, sugar, and urobilinogen were measured, but no change in each group due to ingestion was observed.

<実施例3>
ショウガエキス添加量による好酸球炎症性タンパク質産生抑制効果の検討を行なった。
<Example 3>
The eosinophilic inflammatory protein production inhibitory effect by the addition amount of ginger extract was examined.

ショウガエキスは以下のような方法で作成した。まず、凍結乾燥ショウガ(高知県産のおたふくショウガ2022g)148gを粉末にしたもの(収量7.3%)を10mg/ml純水で抽出した。これをさらに遠心分離し、その上清を適宜希釈したものをショウガエキスとした。   The ginger extract was prepared by the following method. First, 148 g of freeze-dried ginger (2022 g of mumps from Kochi Prefecture) (yield 7.3%) was extracted with 10 mg / ml pure water. This was further centrifuged, and the supernatant was appropriately diluted to obtain a ginger extract.

ヒト好酸球株(HL60 clone15)は誘導、刺激をかけると組織障害性炎症性タンパク質(eosinophil derived neurotoxin)を産生する。刺激をかける際、試料を添加し、その産生量の変動を調べた。べにふうきはタンニン換算で2.5μg/ml添加すると、RANTESで刺激した時よりEDNの産生を抑制する。図8に示すように、ショウガエキス(50μg/ml添加)は、それ自身は抑制効果を持たずに、べにふうきと組み合わせたときに、べにふうきの抑制作用をさらに増強した。   A human eosinophil strain (HL60 clone 15) produces a tissue-damaging inflammatory protein (eosinophil derived neurotoxin) when induced and stimulated. When applying the stimulus, a sample was added, and the variation in the production amount was examined. Benifukuki, when added at 2.5 μg / ml in terms of tannin, suppresses EDN production more than when stimulated with RANTES. As shown in FIG. 8, ginger extract (added with 50 μg / ml) itself has no inhibitory effect, and when combined with Benifuuki, it further enhanced the inhibitory effect of Benifuuki.

<実施例4>
ショウガエキス添加量によるマスト細胞ヒスタミン遊離産生抑制効果の検討を行なった。
<Example 4>
The inhibitory effect of mast cell histamine release production by the amount of ginger extract added was examined.

本実施例においても実施例1と同じショウガエキスを使用した。マウス骨髄誘導マスト細胞(BMMC)をアレルゲン特異的IgE抗体で感作後、アレルゲンで刺激すると炎症性物質ヒスタミンを遊離する。べにふうきはヒスタミン遊離抑制効果をもつ。ショウガエキスは、それ自身はヒスタミン遊離抑制効果は低いが、べにふうきに組み合わせると、図9に示すように、べにふうきが持つヒスタミン抑制効果をさらに増強した。   In this example, the same ginger extract as in Example 1 was used. After sensitizing mouse bone marrow derived mast cells (BMMC) with an allergen-specific IgE antibody, the inflammatory substance histamine is released when stimulated with allergen. Benifuuki has an inhibitory effect on histamine release. The ginger extract itself has a low histamine release inhibitory effect, but when combined with Benifuuki, as shown in FIG. 9, it further enhanced the histamine inhibitory effect of Benifuuki.

<実施例5>
ショウガエキスによるマスト細胞好酸球遊走因子産生抑制増強効果
本実施例におけるショウガエキスは、しょうがをすりおろして50%エタノールに30分浸漬させ、さらに遠心分離したものを用いた。
<Example 5>
Mast cell eosinophil migration factor production inhibitory enhancement effect by ginger extract The ginger extract in this example was grated ginger, soaked in 50% ethanol for 30 minutes, and further centrifuged.

マウス骨髄誘導マスト細胞(BMMC)はアレルゲン特異的IgE感作後、アレルゲンで刺激すると好酸球遊走因子(MIP1−α)を産生し、べにふうきは、その産生量を抑制する。図10に示すように、ショウガエキスはそれ自身強いMIP−α産生抑制作用をもつが、べにふうきと組み合わせるとさらにMIP1−α産生抑制作用が増強された。   Mouse bone marrow derived mast cells (BMMC), after sensitization with allergen-specific IgE, produce eosinophil migration factor (MIP1-α) when stimulated with allergen, and Benifukuki suppresses its production. As shown in FIG. 10, the ginger extract itself has a strong MIP-α production inhibitory effect, but when combined with Benifuuki, the MIP1-α production inhibitory effect was further enhanced.

実施例1に示すショウガエキスによるマスト細胞炎症性サイトカイン産生抑制増強効果を示した図である。It is the figure which showed the mast cell inflammatory cytokine production suppression suppression effect by the ginger extract shown in Example 1. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例2におけるアレルギー日誌に基づいて算出したスコアを示した図である。It is the figure which showed the score calculated based on the allergy diary in Example 2. FIG. 実施例3に示すショウガエキスによる好酸球炎症性タンパク質産生抑制効果を示した図である。It is the figure which showed the eosinophil inflammatory protein production inhibitory effect by the ginger extract shown in Example 3. 実施例4に示すショウガエキスによるマスト細胞ヒスタミン遊離産生抑制効果を示した図である。It is the figure which showed the mast cell histamine release production inhibitory effect by the ginger extract shown in Example 4. 実施例5に示すショウガエキスによるマスト細胞好酸球遊走因子産生抑制増強効果を示した図である。It is the figure which showed the mast cell eosinophil migration factor production suppression enhancement effect by the ginger extract shown in Example 5.

Claims (8)

抗アレルギー成分を含有する緑茶若しくは包種茶の抽出物を抗アレルギー有効成分量含有し、かつ、抗アレルギー成分活性物質を含有する野菜抽出物を、少なくとも抗アレルギー成分活性増強量含有する機能性飲食品。   Functional foods and drinks containing an antiallergic active ingredient amount of green tea or baled tea extract containing an antiallergic component, and at least an antiallergic component activity enhancing amount containing an antiallergic component active substance Goods. 前記抗アレルギー成分は、メチル化カテキンである請求項1に記載の機能性飲料。   The functional beverage according to claim 1, wherein the antiallergic component is methylated catechin. 前記緑茶又は包種茶は、べにふうき、べにふじ、べにほまれ、やえほ、するがわせ、ゆたかみどり、かなやみどり、青心大パン、青心烏龍、大葉烏龍、べにひかり、やまかい、やまとみどり、おくみどり、台湾系統種、中国種もしくはこれらの混合物の茶葉である請求項1又は2に記載の機能性飲食品。   The green tea or baked tea is Benifukuki, Benifuji, Benihore, Yaeho, Surugasuse, Yutaka Midori, Kanaya Midori, Seishin Daipan, Seishin Soryu, Ooba Souryu, Benihikari The functional food or drink according to claim 1 or 2, which is tea leaves of Yamakai, Yamato Midori, Okumidori, Taiwanese species, Chinese species or a mixture thereof. 前記野菜抽出物は、ショウガ、大根、キャベツ、ルッコラスプラウト、かいわれ大根、レッドキャベツスプラウト、ブロッコリスプラウト、フキ、ゴボウ、きゅうり、ナス、白菜、レタス、ラッキョウ、玉ねぎ、長ネギ、カブ、シソ若しくはこれらの抽出物の混合物である請求項1から3いずれかに記載の機能性飲食品。   The vegetable extract is ginger, radish, cabbage, arugula sprout, beetroot radish, red cabbage sprout, broccoli sprout, burdock, burdock, cucumber, eggplant, Chinese cabbage, lettuce, raccoon, onion, long onion, turnip, perilla or extract thereof The functional food or drink according to any one of claims 1 to 3, which is a mixture of foods. 前記緑茶又は包種茶の抽出物又は粉末を、100ml当たり50mgから50g又は100mg当たり5mgから80mg含有する請求項1から4いずれかに記載の機能性飲食品。   The functional food or drink according to any one of claims 1 to 4, comprising 50 mg to 50 g per 100 ml or 5 mg to 80 mg per 100 mg of the extract or powder of the green tea or confectionery tea. 前記野菜抽出物を、100ml当たり2mlから50ml又は100mg当たり1mgから80mg含有する請求項1から5いずれかに記載の機能性飲食品。   The functional food or drink according to any one of claims 1 to 5, wherein the vegetable extract contains 2 to 50 ml per 100 ml or 1 to 80 mg per 100 mg. 抗アレルギー成分を含有する緑茶又は包種茶の抽出物に、野菜抽出物を添加することによって前記抗アレルギー成分の抗アレルギー活性を増強させる方法。   A method of enhancing the antiallergic activity of the antiallergic component by adding a vegetable extract to an extract of green tea or baling tea containing the antiallergic component. 前記抗アレルギー成分は、メチル化カテキンである請求項7に記載の方法。
The method according to claim 7, wherein the antiallergic component is methylated catechin.
JP2005263779A 2005-01-26 2005-09-12 Functional food and drink Active JP4788994B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005263779A JP4788994B2 (en) 2005-01-26 2005-09-12 Functional food and drink

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005017944 2005-01-26
JP2005017944 2005-01-26
JP2005263779A JP4788994B2 (en) 2005-01-26 2005-09-12 Functional food and drink

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011086500A Division JP5754003B2 (en) 2005-01-26 2011-04-08 Antiallergic agent and antiallergic activity enhancer

Publications (3)

Publication Number Publication Date
JP2006232805A true JP2006232805A (en) 2006-09-07
JP2006232805A5 JP2006232805A5 (en) 2007-05-10
JP4788994B2 JP4788994B2 (en) 2011-10-05

Family

ID=37040849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005263779A Active JP4788994B2 (en) 2005-01-26 2005-09-12 Functional food and drink

Country Status (1)

Country Link
JP (1) JP4788994B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008178320A (en) * 2007-01-23 2008-08-07 Asahi Soft Drinks Co Ltd Method for producing green tea beverage group packed in container
JP2008178319A (en) * 2007-01-23 2008-08-07 Asahi Soft Drinks Co Ltd Method for producing green tea beverage group packed in container
JP2008297209A (en) * 2007-05-29 2008-12-11 Yomeishu Seizo Co Ltd Lipid metabolism-improving composition
WO2009002298A1 (en) * 2007-06-22 2008-12-31 Supranaturals, Llc Antioxidant drink for dietary supplementation
WO2011042958A1 (en) * 2009-10-06 2011-04-14 森永製菓株式会社 Polyphenol compound absorption promoter and utilization of same
JP2012090526A (en) * 2010-10-22 2012-05-17 Suntory Holdings Ltd Method for producing ginger extract
CN102987473A (en) * 2012-07-18 2013-03-27 徐州康汇百年食品有限公司 Burdock-cucumber compound health-care beverage
JP2014132850A (en) * 2013-01-09 2014-07-24 Asahi Soft Drinks Co Ltd Acidic beverage and method for inhibiting proliferation of heat-resistant acidophilic bacterium
JP2017128488A (en) * 2016-01-19 2017-07-27 敏明 齋藤 Production method of composition containing component derived from natural product, composition containing component derived from natural product, and functional food and drink using the same
CN114617871A (en) * 2020-12-11 2022-06-14 丰田自动车株式会社 Dipeptidyl peptidase IV inhibitor and functional labeled food

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104222398A (en) * 2014-09-13 2014-12-24 合肥瑾翔医药科技有限公司 Tea beverage powder with function of relieving fatigue and preparation method of tea beverage powder

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041473A (en) * 1983-08-15 1985-03-05 Shiraimatsu Shinyaku Kk Antimicrobial agent
JPH01180822A (en) * 1988-01-12 1989-07-18 Dainippon Pharmaceut Co Ltd Anti-delayed type allergic agent
JPH03157330A (en) * 1989-11-13 1991-07-05 Itouen:Kk Antiallergic agent
JPH08205818A (en) * 1995-02-01 1996-08-13 Nonogawa Shoji Kk Health food and medicine formulated with procyanidin
JP2000159670A (en) * 1998-11-20 2000-06-13 Natl Res Inst Of Vegetables Ornamental Plants & Tea Antiallergic agent
JP2001064192A (en) * 1999-08-25 2001-03-13 Sunstar Inc Migration inhibitor for langerhans cell and antigen presentation inhibitor
JP2002154979A (en) * 2000-11-08 2002-05-28 Tenshinshi Einrei Eiyo Hokenhin Yugenkoshi Medicine composition for i type allergy and method for producing the same
WO2004012655A2 (en) * 2002-08-06 2004-02-12 The Quigley Corporation Anti-microbial compositions and methods of using same
JP2004537575A (en) * 2001-08-06 2004-12-16 ザ キグリー コーポレーション Nutritional supplements and their use

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041473A (en) * 1983-08-15 1985-03-05 Shiraimatsu Shinyaku Kk Antimicrobial agent
JPH01180822A (en) * 1988-01-12 1989-07-18 Dainippon Pharmaceut Co Ltd Anti-delayed type allergic agent
JPH03157330A (en) * 1989-11-13 1991-07-05 Itouen:Kk Antiallergic agent
JPH08205818A (en) * 1995-02-01 1996-08-13 Nonogawa Shoji Kk Health food and medicine formulated with procyanidin
JP2000159670A (en) * 1998-11-20 2000-06-13 Natl Res Inst Of Vegetables Ornamental Plants & Tea Antiallergic agent
JP2001064192A (en) * 1999-08-25 2001-03-13 Sunstar Inc Migration inhibitor for langerhans cell and antigen presentation inhibitor
JP2002154979A (en) * 2000-11-08 2002-05-28 Tenshinshi Einrei Eiyo Hokenhin Yugenkoshi Medicine composition for i type allergy and method for producing the same
JP2004537575A (en) * 2001-08-06 2004-12-16 ザ キグリー コーポレーション Nutritional supplements and their use
WO2004012655A2 (en) * 2002-08-06 2004-02-12 The Quigley Corporation Anti-microbial compositions and methods of using same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"ショウキョウエキス", アルプス薬品工業株式会社ウェブサイト, JPN6010073346, ISSN: 0001812517 *
MARI MAEDA-YAMAMOTO ET AL.: "Effects of Tea Infusions of Various Varieties or Different Manufacturing Types on Inhibition of Mous", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 62, no. 11, JPN6010040298, 1998, pages 2277 - 2279, ISSN: 0001677166 *
山原條治 他: "生姜修治の薬理学的解明 I Gingerol類及びShogaol類の抗アレルギー活性及び強心活性", NAT MED, vol. 49, no. 1, JPN6010040299, March 1995 (1995-03-01), pages 76 - 83, ISSN: 0001947776 *
立花宏文 他: "茶葉から新たに見つかった抗アレルギー物質ストリクチニン", 農業および園芸, vol. 78, no. 1, JPN6010040293, 1 January 2003 (2003-01-01), pages 7 - 11, ISSN: 0001677165 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008178320A (en) * 2007-01-23 2008-08-07 Asahi Soft Drinks Co Ltd Method for producing green tea beverage group packed in container
JP2008178319A (en) * 2007-01-23 2008-08-07 Asahi Soft Drinks Co Ltd Method for producing green tea beverage group packed in container
JP2008297209A (en) * 2007-05-29 2008-12-11 Yomeishu Seizo Co Ltd Lipid metabolism-improving composition
WO2009002298A1 (en) * 2007-06-22 2008-12-31 Supranaturals, Llc Antioxidant drink for dietary supplementation
WO2011042958A1 (en) * 2009-10-06 2011-04-14 森永製菓株式会社 Polyphenol compound absorption promoter and utilization of same
JPWO2011042958A1 (en) * 2009-10-06 2013-02-28 森永製菓株式会社 Absorption accelerator for polyphenol compounds and use thereof
JP2012090526A (en) * 2010-10-22 2012-05-17 Suntory Holdings Ltd Method for producing ginger extract
CN102987473A (en) * 2012-07-18 2013-03-27 徐州康汇百年食品有限公司 Burdock-cucumber compound health-care beverage
JP2014132850A (en) * 2013-01-09 2014-07-24 Asahi Soft Drinks Co Ltd Acidic beverage and method for inhibiting proliferation of heat-resistant acidophilic bacterium
JP2017128488A (en) * 2016-01-19 2017-07-27 敏明 齋藤 Production method of composition containing component derived from natural product, composition containing component derived from natural product, and functional food and drink using the same
CN114617871A (en) * 2020-12-11 2022-06-14 丰田自动车株式会社 Dipeptidyl peptidase IV inhibitor and functional labeled food

Also Published As

Publication number Publication date
JP4788994B2 (en) 2011-10-05

Similar Documents

Publication Publication Date Title
JP4788994B2 (en) Functional food and drink
KR100842634B1 (en) Physiologically functional drinks and compositions
JP4742752B2 (en) Beverage production method
CA2520207C (en) Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
KR102127911B1 (en) The composition of fermented beverage for immunity enhancement and method for production thereof
JP5261808B2 (en) Fat accumulation inhibitor, medicine and method for newly imparting fat accumulation inhibitory action
Nguekouo et al. Effect of boiling and roasting on the antidiabetic activity of Abelmoschus esculentus (Okra) fruits and seeds in type 2 diabetic rats
JP4997523B2 (en) Antiallergic agents, foods and drinks containing them, external preparations, cosmetics
JP2009298769A (en) Fat accumulation-suppressing composition
KR102483300B1 (en) Composition for improving muscle atrophy comprising ginsenoside Rf, ginsenoside composition comprising gincenoside Rf, or mixture thereof as an effective component
KR101318296B1 (en) Composition for Prevention or Treatment of Osteoporosis Comprising Essential Oil of Zanthoxylum schinifolium
JPWO2004112817A1 (en) Celery family-derived extract and method for producing the same
KR20160141027A (en) Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder
JP5754003B2 (en) Antiallergic agent and antiallergic activity enhancer
KR102191409B1 (en) Food compositions containing red ginseng and lactic acid fermentation broth and method for preparing the same
KR102252268B1 (en) Preparation manufacturing of composition for the improving of respiratory disease comprising pear and citron, and composition prepared thereby
JP2015010067A (en) Liver function improvement formulation
TWI627962B (en) Composition for improving blood glucose metabolism
KR102178199B1 (en) a composition comprising an extract of Rhus verniciflua and Eucommia ulmoides, as an active ingredient for preventing or treating obesity
KR101910099B1 (en) Compositions for improving lipid metabolism or anti-obesity as an active ingredient extracted from an immature persimmon by pressurized hydrothermal method
KR101089314B1 (en) Composition containing euphobiasteroid for prevention, treatment or improvement of obesity
KR102649974B1 (en) Composition for improving muscle function comprising ginsenoside Rf, ginsenoside composition comprising gincenoside Rf, or mixture thereof as an effective component
WO2006064761A1 (en) Adiponectin regultor and foods, drinks, food aditives and drugs containing the same
KR101629642B1 (en) Food composition, pharmaceutical composition, animal medicine and feed composition against fatty liver with piperlongumine
KR102468526B1 (en) Composition for preventing or treating aryl hydrocarbon receptor-mediated diseases derived from environmental pollutants comprising deer antler extract and gangliosides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070315

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100720

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100901

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101015

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110408

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110628

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110707

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140729

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4788994

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250